ITGAM and neoplasm: Deletion of the type II TGF-β receptor gene (Tgfbr2) in mammary carcinomas results in the recruitment of Gr-1+CD11b+ MDSCs that directly promoted tumor metastasis through enhanced metalloproteinase and TGF-β production [94].